Episode
Noom Expands Blood Testing, Gene Editing Targets Cholesterol, Retro Biosciences Surges
- Podcast
- Fitt Insider
- Published
- May 29, 2026
- Duration seconds
- 162
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/fitt-insider-254580/episodes/noom-expands-blood-testing-gene-editing-targets-cholesterol-retro-biosciences-surges/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/fitt-insider-254580/noom-expands-blood-testing-gene-editing-targets-cholesterol-retro-biosciences-surges.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
May 29, 2026: Your daily rundown of health and wellness news, in under 5 minutes. Today's top stories: Noom launches at-home biomarker kits measuring 17 markers with microneedle collection, finding 70% of users have high LDL cholesterol despite appearing healthy Scientists report single gene-editing infusion lowering LDL cholesterol by 62% with results maintained 18+ months, potentially replacing years of daily medication Retro Biosciences reaches $1.8B valuation backed by Sam Altman, entering human trials testing cellular cleanup process to combat neurodegeneration and age-related disease More from Fitt: Fitt Insider breaks down the convergence of fitness, wellness, and healthcare — and what it means for business, culture, and capital. Subscribe to our newsletter → insider.fitt.co/subscribe Work with our recruiting firm → https://talent.fitt.co/ Follow us on Instagram → https://www.instagram.com/fittinsider/ Follow us on LinkedIn → linkedin.com/company/fittinsider Reach out → [email protected]